Carolinas Wealth Consulting’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Carolinas Wealth Consulting's BSX Position: Q2 2025 in Review
Carolinas Wealth Consulting sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 524 shares — an estimated $52.9K sold.
Carolinas Wealth Consulting first reported a position in BSX in Q2 2020 and held it in 20 quarters. The position peaked at $56.4K in Q2 2024. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.
- Carolinas Wealth Consulting reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
- Carolinas Wealth Consulting sold 524 Boston Scientific shares in Q2 2025, an estimated $52.9K.
- Carolinas Wealth Consulting first reported a position in Boston Scientific in Q2 2020 and held it in 20 quarters.
- Carolinas Wealth Consulting's Boston Scientific position peaked at $56.4K in Q2 2024.
- 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.
Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.